115 related articles for article (PubMed ID: 37302518)
1. HHEX suppresses advanced thyroid cancer by interacting with TLE3.
Xu Z; Feng Y; Yan Y; Jin H; Chen Y; Han Y; Huang S; Feng F; Fu H; Yin Y; Huang Y; Wang H; Cheng W
Mol Cell Endocrinol; 2023 Aug; 574():111988. PubMed ID: 37302518
[TBL] [Abstract][Full Text] [Related]
2. RNF6 Promotes Colorectal Cancer by Activating the Wnt/β-Catenin Pathway via Ubiquitination of TLE3.
Liu L; Zhang Y; Wong CC; Zhang J; Dong Y; Li X; Kang W; Chan FKL; Sung JJY; Yu J
Cancer Res; 2018 Apr; 78(8):1958-1971. PubMed ID: 29374067
[TBL] [Abstract][Full Text] [Related]
3. The transcription factor Hhex cooperates with the corepressor Tle3 to promote memory B cell development.
Laidlaw BJ; Duan L; Xu Y; Vazquez SE; Cyster JG
Nat Immunol; 2020 Sep; 21(9):1082-1093. PubMed ID: 32601467
[TBL] [Abstract][Full Text] [Related]
4. Transmembrane protein 88 exerts a tumor-inhibitory role in thyroid cancer through restriction of Wnt/β-catenin signaling.
Geng Q; Chen X; Chen N
Exp Cell Res; 2020 Oct; 395(2):112193. PubMed ID: 32710906
[TBL] [Abstract][Full Text] [Related]
5. Wnt/β-catenin signaling pathway is a direct enhancer of thyroid transcription factor-1 in human papillary thyroid carcinoma cells.
Gilbert-Sirieix M; Makoukji J; Kimura S; Talbot M; Caillou B; Massaad C; Massaad-Massade L
PLoS One; 2011; 6(7):e22280. PubMed ID: 21814573
[TBL] [Abstract][Full Text] [Related]
6. CENPA knockdown restrains cell progression and tumor growth in breast cancer by reducing PLA2R1 promoter methylation and modulating PLA2R1/HHEX axis.
Wu G; Fan Z; Li X
Cell Mol Life Sci; 2024 Jan; 81(1):27. PubMed ID: 38212546
[TBL] [Abstract][Full Text] [Related]
7. Hhex inhibits cell migration via regulating RHOA/CDC42-CFL1 axis in human lung cancer cells.
Li X; Ma G; Guo W; Mu N; Wang Y; Liu X; Su L
Cell Commun Signal; 2021 Jul; 19(1):80. PubMed ID: 34321041
[TBL] [Abstract][Full Text] [Related]
8. FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt/β-catenin pathway.
Ma J; Huang X; Li Z; Shen Y; Lai J; Su Q; Zhao J; Xu J
J Cell Physiol; 2019 Aug; 234(10):17739-17748. PubMed ID: 30793770
[TBL] [Abstract][Full Text] [Related]
9. SOX18 exerts tumor-suppressive functions in papillary thyroid carcinoma through inhibition of Wnt/β-catenin signaling.
Geng Q; Deng H; Fu J; Cui F
Exp Cell Res; 2020 Nov; 396(1):112249. PubMed ID: 32858034
[TBL] [Abstract][Full Text] [Related]
10. ZNRF3 is downregulated in papillary thyroid carcinoma and suppresses the proliferation and invasion of papillary thyroid cancer cells.
Qiu W; Yang Z; Fan Y; Zheng Q
Tumour Biol; 2016 Sep; 37(9):12665-12672. PubMed ID: 27448298
[TBL] [Abstract][Full Text] [Related]
11. Methylation of DACT2 promotes papillary thyroid cancer metastasis by activating Wnt signaling.
Zhao Z; Herman JG; Brock MV; Sheng J; Zhang M; Liu B; Guo M
PLoS One; 2014; 9(11):e112336. PubMed ID: 25375359
[TBL] [Abstract][Full Text] [Related]
12. Downregulated GBX2 gene suppresses proliferation, invasion and angiogenesis of breast cancer cells through inhibiting the Wnt/β-catenin signaling pathway.
Fang Y; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
Cancer Biomark; 2018; 23(3):405-418. PubMed ID: 30223390
[TBL] [Abstract][Full Text] [Related]
13. Expression of TLE3 by bone marrow stromal cells is regulated by canonical Wnt signaling.
Kokabu S; Sato T; Ohte S; Enoki Y; Okubo M; Hayashi N; Nojima J; Tsukamoto S; Fukushima Y; Sakata Y; Katagiri T; Rosen V; Yoda T
FEBS Lett; 2014 Feb; 588(4):614-9. PubMed ID: 24444608
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt/β-catenin signaling pathway.
Zhou Z; Liu Y; Ma M; Chang L
Biomed Pharmacother; 2017 Dec; 96():98-103. PubMed ID: 28965013
[TBL] [Abstract][Full Text] [Related]
15. MiR-150 Inhibits Cell Growth In Vitro and In Vivo by Restraining the RAB11A/WNT/β-Catenin Pathway in Thyroid Cancer.
Bai D; Sun H; Wang X; Lou H; Zhang J; Wang X; Jiang L
Med Sci Monit; 2017 Oct; 23():4885-4894. PubMed ID: 29023429
[TBL] [Abstract][Full Text] [Related]
16. A Runaway PRH/HHEX-Notch3-Positive Feedback Loop Drives Cholangiocarcinoma and Determines Response to CDK4/6 Inhibition.
Kitchen P; Lee KY; Clark D; Lau N; Lertsuwan J; Sawasdichai A; Satayavivad J; Oltean S; Afford S; Gaston K; Jayaraman PS
Cancer Res; 2020 Feb; 80(4):757-770. PubMed ID: 31843982
[TBL] [Abstract][Full Text] [Related]
17. KCNIP3 silence promotes proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma through activating Wnt/β-catenin pathway.
Zhong J; Lin R; Wang G; Lin L; Ruan S; Liu W
Tissue Cell; 2022 Apr; 75():101739. PubMed ID: 35066335
[TBL] [Abstract][Full Text] [Related]
18. ANKRD22 knockdown suppresses papillary thyroid cell carcinoma growth and migration and modulates the Wnt/β-catenin signaling pathway.
Wu Y; Chen W; Zhang B; Liu H
Tissue Cell; 2023 Oct; 84():102193. PubMed ID: 37586180
[TBL] [Abstract][Full Text] [Related]
19. Pituitary homeobox 2 (PITX2) promotes thyroid carcinogenesis by activation of cyclin D2.
Huang Y; Guigon CJ; Fan J; Cheng SY; Zhu GZ
Cell Cycle; 2010 Apr; 9(7):1333-41. PubMed ID: 20372070
[TBL] [Abstract][Full Text] [Related]
20. [Nuclear translocation of β-catenin represses membrane localization of NIS in human thyroid cancer cells].
Lan L; Deng W; Chen H; Huo L; Deng L; Zhang G; Luo Y
Zhonghua Yi Xue Za Zhi; 2016 Mar; 96(11):891-6. PubMed ID: 27045654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
